Trial intelligence / Profile preview

A+C+hib Conjugate Vaccine in Infants and Children

NCT01428908Phase 3Completed

Sponsor
Jiangsu Provincial Center for Disease Control and Prevention
Start
Sep 2011
Primary completion
Dec 2011
Countries
1
01

Overview

A Phase 3 trial of Hib-MenAC conjugate vaccine in meningitis, Haemophilus influenzae type b infection (Hib), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Sep 2011; status: completed.

02

Drugs

Hib-MenAC conjugate vaccine
03

Conditions

meningitisHaemophilus influenzae type b infection (Hib)

Beyond the preview

Go deeper on NCT01428908.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01428908.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call